DURHAM, N.C., March 30, 2018 — Predicting the cost of clinical trials is a complex task, and more CROs are providing grant forecasting as a service to produce more accurate projections and give customers greater visibility. A grant forecasting expert from Premier Research will discuss new approaches to predicting trial costs in April at the Clinical Trial Financial Management Summit in Philadelphia.
James Sacchetta, Manager of Technical Operations, will present Grant Forecasting: New Approaches to Predicting Clinical Trial Costs on April 4. Mr. Sacchetta will:
- Explain how continuously evaluating study payments, patient enrollment, and site contract costs can help you adjust cost projections and simplify trial processes.
- Examine enrollment risks, undisclosed site contract costs, and other factors that can drive up site payments.
- Show how real-time assessment of cost variances can produce a clear, data-driven picture of a trial’s cost trajectory.
About Premier Research
Premier Research is a leading clinical development service provider that helps highly innovative biotech, specialty pharma, and medical device companies transform breakthrough ideas into reality. The company has a wealth of experience in the execution of global, regional and local clinical development programs with a special focus on addressing unmet needs in areas such as analgesia, dermatology, medical device, neuroscience, oncology, pediatrics, and rare disease. Premier Research operates in 84 countries and employs 1,100 professionals, including a strong international network of clinical monitors and project managers, regulatory, data management, statistical, scientific, and medical experts. They are focused on smart study design for advanced medicines that allow life-changing treatments.